APOB and depressive symptom measurement: revealed that although there was no dramatic difference in serum apo B levels between individuals with depression and the control group, there were changes in apo B oxidation and serum paraoxonase/arylesterase activity in individuals with MDD, suggesting abnormal lipoprotein metabolism (148).